CAPOTEN Drug Patent Profile
✉ Email this page to a colleague
When do Capoten patents expire, and when can generic versions of Capoten launch?
Capoten is a drug marketed by Strides Pharma and is included in one NDA.
The generic ingredient in CAPOTEN is captopril. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the captopril profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Capoten
A generic version of CAPOTEN was approved as captopril by HIKMA INTL PHARMS on February 13th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CAPOTEN?
- What are the global sales for CAPOTEN?
- What is Average Wholesale Price for CAPOTEN?
Summary for CAPOTEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 118 |
| Clinical Trials: | 5 |
| DailyMed Link: | CAPOTEN at DailyMed |
Recent Clinical Trials for CAPOTEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GlaxoSmithKline | Phase 1 |
| Children's Cancer Hospital Egypt 57357 | Phase 3 |
| University of Nebraska | Phase 4 |
US Patents and Regulatory Information for CAPOTEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-005 | Jan 17, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-004 | Jun 13, 1995 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CAPOTEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-004 | Jun 13, 1995 | ⤷ Sign Up | ⤷ Sign Up |
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-005 | Jan 17, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CAPOTEN
See the table below for patents covering CAPOTEN around the world.
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
